World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
33821
World Ranking
14906
National Ranking
571

Carien L. Creutzberg publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Carien L. Creutzberg sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 423 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Carien L. Creutzberg D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Carien L. Creutzberg sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Carien L. Creutzberg is affiliated with Leiden University Medical Center in the Netherlands. Their research primarily focuses on medicine with a notable emphasis on obstetrics and gynecology, reproductive medicine, oncology, epidemiology, and cancer research.

Creutzberg's work covers multiple interconnected topics in the field of gynecological cancers and reproductive health. Key topics include:

  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Cervical Cancer and HPV Research
  • Endometriosis Research and Treatment
  • Cancer survivorship and care
  • Estrogen and related hormone effects
  • Uterine Myomas and Treatments

Their publication record includes contributions to several prominent scientific journals. Frequent venues for publishing include:

  • Radiotherapy and Oncology
  • International Journal of Gynecological Cancer
  • Gynecologic Oncology
  • Journal of Clinical Oncology
  • Endometrial Cancer

Recent papers by Creutzberg cover significant subjects in gynecologic oncology and endometrial cancer management:

  • ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma, 2020, International Journal of Gynecological Cancer
  • FIGO staging of endometrial cancer: 2023, International Journal of Gynecology & Obstetrics
  • Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy, 2020, Journal of Clinical Oncology
  • Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2022, Annals of Oncology
  • Cancer of the corpus uteri: 2021 update, International Journal of Gynecology & Obstetrics

Throughout their career, Creutzberg has collaborated extensively with several co-authors, reflecting ongoing research partnerships. Frequent collaborators include:

  • Remi A. Nout
  • Nanda Horeweg
  • Tjalling Bosse
  • Stephanie M. de Boer
  • Vincent T.H.B.M. Smit

Best Publications

  • ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, Treatment and Follow-up.

    Nicoletta Colombo;Carien Creutzberg;Frederic Amant;Tjalling Bosse

  • Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial

    Carien L Creutzberg;Wim Lj van Putten;Peter Cm Koper;Marnix Lm Lybeert

  • ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma.

    Nicole Concin;Xavier Matias-Guiu;Ignace Vergote;David Cibula

  • Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial

    RA Nout;Vthbm Smit;H Putter;IM Jürgenliemk-Schulz

  • Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

    Ellen Stelloo;Remi A. Nout;Elisabeth M. Osse;Ina J. Jürgenliemk-Schulz

  • Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial

    Stephanie M. de Boer;Melanie E. Powell;Linda Mileshkin;Dionyssios Katsaros

  • Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy

    Alicia León-Castillo;Stephanie M. de Boer;Melanie E. Powell;Linda R. Mileshkin

  • Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy for the Definitive Treatment of Cervix Cancer

    Karen Lim;William Small;Lorraine Portelance;Carien Creutzberg

  • Consensus guidelines for delineation of clinical target volume for intensity-modulated pelvic radiotherapy in postoperative treatment of endometrial and cervical cancer.

    William Small;Loren K. Mell;Penny Anderson;Carien Creutzberg

  • Survival after relapse in patients with endometrial cancer: results from a randomized trial.

    Carien L Creutzberg;Wim L.J van Putten;Peter C Koper;Marnix L.M Lybeert

  • Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.

    Ellen Stelloo;Tjalling Bosse;Remi A Nout;Helen J MacKay

  • Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): patterns of recurrence and post-hoc survival analysis of a randomised phase 3 trial

    Stephanie M de Boer;Melanie E Powell;Linda Mileshkin;Dionyssios Katsaros

  • Substantial lymph-vascular space invasion (LVSI) is a significant risk factor for recurrence in endometrial cancer - A pooled analysis of PORTEC 1 and 2 trials

    Tjalling Bosse;Elke E.M. Peters;Carien L. Creutzberg;Ina M. Jürgenliemk-Schulz

  • Fifteen-year radiotherapy outcomes of the randomized PORTEC-1 trial for endometrial carcinoma.

    Carien L. Creutzberg;Remi A. Nout;Marnix L. M. Lybeert;Carla C. Warlam-Rodenhuis

  • Outcome of high-risk stage IC, grade 3, compared with stage I endometrial carcinoma patients: the Postoperative Radiation Therapy in Endometrial Carcinoma Trial

    Carien L. Creutzberg;Wim L.J. van Putten;Carla C. Wárlám-Rodenhuis;Alfons C.M. van den Bergh

  • Quality of Life After Pelvic Radiotherapy or Vaginal Brachytherapy for Endometrial Cancer: First Results of the Randomized PORTEC-2 Trial

    Remi A. Nout;Hein Putter;Ina M. Jurgenliemk-Schulz;Jan J. Jobsen

  • Prognostic Significance of POLE Proofreading Mutations in Endometrial Cancer

    David N. Church;David N. Church;Ellen Stelloo;Remi A. Nout;Nadejda Valtcheva

  • Postoperative radiotherapy for Stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review.

    Astrid N. Scholten;Wim L.J. van Putten;Henk Beerman;Vincent T.H.B.M. Smit

  • High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging

    Arjan Bel;Pieter H. Vos;Patrick T.R. Rodrigus;Carien L. Creutzberg

  • Practical guidance for mismatch repair-deficiency testing in endometrial cancer

    E. Stelloo;A.M.L. Jansen;E.M. Osse;R.A. Nout

Frequent Co-Authors

Hans W. Nijman
Hans W. Nijman University Medical Center Groningen
Hein Putter
Hein Putter Leiden University Medical Center
Vincent T.H.B.M. Smit
Vincent T.H.B.M. Smit Leiden University Medical Center
Henry C Kitchener
Henry C Kitchener University of Manchester
Anthony Fyles
Anthony Fyles Princess Margaret Cancer Centre
Christine Haie-Meder
Christine Haie-Meder Institut Gustave Roussy
Jonathan A. Ledermann
Jonathan A. Ledermann University College London
Dionyssios Katsaros
Dionyssios Katsaros University of Turin
Corrie A.M. Marijnen
Corrie A.M. Marijnen Leiden University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t always mean becoming a physician. There are several online degree options and career pathways in the healthcare field that can complement or offer alternatives to traditional routes.

For those interested in healthcare management, consider enrolling in cahme accredited mha online programs for industry-recognized training and leadership skills. Nursing professionals seeking to further their qualifications but hoping to bypass clinical requirements can look into rn to bsn programs that are designed without clinicals.

Accelerated degree paths are also available for nurses aiming for advanced practice or leadership roles. The shortest msn to dnp program options allow busy professionals to progress quickly. Similarly, the shortest dnp program can help you achieve a terminal degree in nursing with greater speed and flexibility.

Each of these pathways supports growing demand in healthcare for skilled clinicians, administrators, and leaders—making them worth considering as part of your medical career journey.

Best Scientists Citing Carien L. Creutzberg

Trending Scientists

Recently Published Articles